Actimmune

This page contains recent news articles, when available, and an overview of Actimmune but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

FDA panel: Gilead Sciences drug to treat deadly lung infection appears safe ...  -  ‎Dec 10, 2009‎
FRANCISCO — The former chief executive of the biotechnology company InterMune Inc. has been convicted of wire fraud in marketing of the drug Actimmune. ... Gaea Times (blog)

InterMune, Inc. Q3 2009 Earnings Call Transcript  -  ‎Nov 10, 2009‎
Throughout the call, we will refer to our commercial product, interferon gamma-1b, using its trade name, Actimmune, even when describing investigational ... Seeking Alpha (blog)

InterMune Reports Third Quarter 2009 Financial Results and Business Highlights  -  ‎Nov 5, 2009‎
Actimmune revenue totaled $19.6 million in the first nine months of 2009, compared with $23.3 million of Actimmune revenue in the first nine months of 2008, ... CNNMoney.com (press release)

InterMune Inc. Reports Operating Results (10-Q)  -  ‎Nov 6, 2009‎
The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other ... GuruFocus.com

InterMune Q3 Loss Narrows; Updates FY09 Revenue Guidance - Quick Facts  -  ‎Nov 5, 2009‎
...(RTTNews) - InterMune Inc. (ITMN: News ) reported a third-quarter net loss of $8.771 million or $0.19 per share compared to a net loss of $13.982 million or ... RTT News

How Hard Should It Be to Imprison Someone for Telling the Truth?  -  ‎Oct 20, 2009‎
Th us, off -label use of Actimmune for IPF likely began shortly aft er the article was published in the New England Journal of Medicine. ... Linex Legal (registration)

Hard Time For Biopharma CEOs (Part 2)  -  ‎Oct 29, 2009‎
...facing jail time after being convicted of wire fraud in a case involving claims that the company inappropriately promoted Actimmune via a press release. ... The IN VIVO Blog (blog)

BUYINS.NET: JAZZ, ITMN, HSTX, PDC, CHINA, ELON Expected To Be Lower After ...  -  ‎Nov 2, 2009‎
It offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease in the United States. ... TMC Net





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy